European Union nations expressed frustration at the delay because they are waiting desperately for more doses to immunise people against the virus that has claimed almost two million lives worldwide
Pfizer's Covid-19 vaccine found effective against UK, SA variants of SARS-CoV-2 virus, study reports
The study noted that the Pfizer–BioNTech shot worked against 15 additional possible mutations in the SARS-CoV-2 virus.
BioNTech held webinars for nurses and doctors who will soon administer the shot, with 1,100 questions answered during the sessions.
Coronavirus News Updates: Covaxin displaying encouraging results in clinical trial, claims Bharat Biotech
Coronavirus News Updates: Covaxin, being developed in collaboration with the Indian Council of Medical Research and the National Institute of Virology, is now undergoing Phase 3 trials
BioNTech's vaccine, developed together with US pharmaceutical company Pfizer, is authorised for use in more than 45 countries including Britain, the United States and the European Union
Almost two billion doses of candidate vaccines have been secured for the Covax facility, created by the UN health agency, to ensure fair access
Initial doses are scarce and rationed as the US joins Britain and several other countries in scrambling to vaccinate as many people as possible
The companies stated that. “EMA has assured us that the cyber attack will have no impact on the timeline for its review.”
Albert Bourla said he understood the concerns around the speed at which the vaccines had been developed. "There are always people who are sceptical about vaccines, but I have to say they are wrong," he added
The FDA, however, also said that more research was needed to confirm evidence that the vaccine prevents even the worst cases of COVID-19, offers protection after the first of two doses and that the vaccine works for people who have previously been infected by the virus
In November, Bahrain had already granted emergency-use authorization for a Chinese vaccine made by Sinopharm and has inoculated some 6,000 people with it
If Johnson accepts the invite, he would become the first British prime minister to grace the parade at Rajpath in nearly three decades
Peter Liese, an EU lawmaker and a member of Angela Merkel's party, in a statement called the decision as problematic and said the process followed by the European regulator EMA was better
The Pfizer-BioNTech vaccine must be transported at South Pole-like temperatures, a requirement that is already dictating who will be vaccinated in the UK
The UK government says frontline health care workers and nursing home residents will be first in line to get vaccinated.
Moderna says its vaccine 94% effective against COVID-19, asks European and US regulators for emergency use
The US pharma company said it was on track to have about 20 million doses of its vaccine ready to ship in America by 2020-end
Oxford-AstraZeneca COVID-19 vaccine will be available at cost price across world, says pharma head Olivier Nataf
Unlike the two vaccines produced by Moderna and Pfizer-BioNTech, which require ultra-cold storage, the AstraZeneca vaccine can be kept in the conventional fridge used to store vaccines around the world
The company didn’t disclose safety details but said no serious side effects have been reported, with the most common problem being fatigue after the second vaccine dose, affecting about four percent of participants
WHO hails COVID-19 vaccine news after Moderna's progress, but warns there's 'no time for complacency'
WHO chief Tedros Adhanom Ghebreyesus warned that widespread availability of any vaccine remains a long way off, amid rising COVID-19 cases and deaths across the world
In Germany, where immigration continues to be a fractious issue, the success of two scientists of Turkish descent was cause for celebration